Events
Event Name
Date
Status
Action
Dec 11 2024
11:30 AM EST Dec 11 2024, 11:30 AM EST
Upcoming
11:30 AM EST Dec 11 2024, 11:30 AM EST
CNS Pharmaceuticals to Host Virtual Analyst & Investor Day
Nov 22 2024
8:30 PM - 10:30 PM EST Nov 22 2024, 8:30 PM - 10:30 PM EST
Archived
8:30 PM - 10:30 PM EST Nov 22 2024, 8:30 PM - 10:30 PM EST
Update on a Potentially Pivotal Trial CNS-201: A Randomized, Controlled Trial of Berubicin Vs. Lomustine After First-Line Therapy for Glioblastoma Multiforme (GBM)
Sep 09 2024
7:00 AM EDT Sep 09 2024, 7:00 AM EDT
Archived
7:00 AM EDT Sep 09 2024, 7:00 AM EDT
CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Aug 28 2024
10:56 PM EDT Aug 28 2024, 10:56 PM EDT
Archived
10:56 PM EDT Aug 28 2024, 10:56 PM EDT
LIVE! with Webull Corporate Connect: Biotech Investment Webinar
Aug 26 2024
12:00 PM EDT Aug 26 2024, 12:00 PM EDT
Archived
12:00 PM EDT Aug 26 2024, 12:00 PM EDT
Virtual Investor CEO Connect Segment
Jul 30 2024
8:30 AM EDT Jul 30 2024, 8:30 AM EDT
Archived
8:30 AM EDT Jul 30 2024, 8:30 AM EDT
CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Blood Brain Barrier Permeable Taxane for Treatment of Brain Malignancies
There are no events that match the selected filters.
View More
Stay Updated
Your email alerts were set.
The following alerts could not be set: